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ABSTRACT
Meganucleases cut long (>12bp) unique sequences
in genomes and can be used to induce targeted
genome engineering by homologous recombination
in the vicinity of their cleavage site. However, the
use of natural meganucleases is limited by the
repertoire of their target sequences, and consider-
able efforts have been made to engineer redesigned
meganucleases cleaving chosen targets. Homodi-
meric meganucleases such as I-CreI have provided
a scaffold, but can only be modified to recognize
new quasi-palindromic DNA sequences, limiting
their general applicability. Other groups have used
dimer-interface redesign and peptide linkage to
control heterodimerization between related mega-
nucleases such as I-DmoI and I-CreI, but until now
there has been no application of this aimed
specifically at the scaffolds from existing combina-
torial libraries of I-CreI. Here, we show that
engineering meganucleases to form obligate het-
erodimers results in functional endonucleases that
cut non-palindromic sequences. The protein design
algorithm (FoldX v2.7) was used to design specific
heterodimer interfaces between two meganuclease
monomers, which were themselves engineered to
recognize different DNA sequences. The new mono-
mers favour functional heterodimer formation and
prevent homodimer site recognition. This design
massively increases the potential repertoire of DNA
sequences that can be specifically targeted by
designed I-CreI meganucleases and opens the way
to safer targeted genome engineering.
INTRODUCTION
By deﬁnition, meganucleases are sequence-speciﬁc endo-
nucleases with large (12–45bp) cleavage sites (1), and they
can be used to achieve very high levels of gene targeting
eﬃciencies in mammalian cells and plants (2–6). Indeed,
meganuclease-induced recombination is an eﬃcient and
robust method for genome engineering; the nuclease cuts
the genome and a supplied exogenous DNA recombines
near the break to repair or mutate the region. The major
limitation until recently was the requirement for the prior
introduction of a meganuclease target site in the locus of
interest, but this has now been overcome by developing
protein engineering approaches (7–9).
In nature, meganucleases are essentially represented by
homing endonucleases (HEs), a widespread family of
endonucleases including hundreds of proteins (10,11).
These proteins are encoded by mobile genetic elements
which propagate by a process called ‘homing’: the
endonuclease cleaves a cognate allele from which the
mobile element is absent, thereby stimulating a homo-
logous recombination event that duplicates the mobile
DNA into the recipient locus (12,13). Given their natural
function and their exceptional cleavage properties in terms
of eﬃcacy and speciﬁcity, HEs provide ideal scaﬀolds to
derive novel endonucleases for genome engineering. Data
have accumulated over the last decade, allowing a good
characterization of the LAGLIDADG family, the largest
of the four HE families (10).
LAGLIDADG refers to the only sequence actually
conserved throughout the family, and is found in one or
(more often) two copies in the protein. Proteins with
a single motif, such as I-CreI (14), form homodimers
and cleave palindromic or pseudo-palindromic DNA
sequences, whereas the larger, double-motif proteins,
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targets. Nine diﬀerent LAGLIDADG proteins have been
crystallized, showing a very striking core structure
conservation that contrasts with the lack of similarity at
the primary sequence level (10,11,15–23). In this core
structure, two characteristic abbabba folds, contributed
by two monomers, or two domains in double
LAGLIDAG proteins, are facing each other with a
2-fold symmetry. DNA binding depends on the four
b-strands from each domain, folded into an anti-parallel
b-sheet, and forming a saddle on the DNA helix major
groove. The catalytic site is central, formed with
contributions from helices of both monomers. In addition
to this core structure, other domains can be found; for
instance, the intein PI-SceI has a protein splicing domain,
and an additional DNA-binding domain (18,24).
The extensive structural conservation within the mega-
nuclease family has encouraged the mutagenesis and
construction of chimeric and single chain HEs (25–27),
which withstood extensive modiﬁcations (25–27).
Seligman and co-workers (28,29) used a rational approach
to substitute speciﬁc individual residues of the I-CreI
abbabba fold, and could observe substantial cleavage of
novel targets. The same kind of approach was applied to
I-SceI recently by another group (30). In a similar way,
Gimble and co-workers (31) modiﬁed the additional
DNA-binding domain of PI-SceI, and could obtain
variant proteins with altered binding speciﬁcity. Recent
work has shown that it is possible to obtain a large
number of locally altered variants of the I-CreI mega-
nuclease that recognize a wide variety of targets (7), and to
use and assemble them by a combinatorial process, to
obtain entirely redesigned mutants with chosen speciﬁcity
(8,9). These variants can be used to cleave genuine
chromosomal sequences and open a wide range of
applications, including the correction of mutations
responsible for inherited monogenic diseases (5).
A limiting factor that still remains for the widespread
use of the I-CreI meganuclease is the fact that the protein
is a homodimer. Thus, although we have experimental
evidence that mixing two meganucleases that target two
diﬀerent DNA sequences can result in formation of a
heterodimer that recognizes a hybrid DNA sequence
(7–9), this still results in a mixture of three diﬀerent
enzymes, including both homodimers (7).
Here, by using the protein design algorithm FoldX
(32–34), we have re-designed the interaction surface of the
I-CreI meganuclease to obtain an obligatory heterodimer
to prefer a single DNA target sequence. Previous studies
in the ﬁeld have already used computational design to
redesign meganuclease interfaces such that I-CreI and
I-DmoI monomers can be made to dimerize or form
chimeras with peptide linkage (26,35,36). The I-CreI
scaﬀold is less amenable to such linkage because the
N- and C-termini from adjacent monomers are relatively
far apart (68A ˚ ). This prompted us to consider engineering
obligate heterodimers, as has been recently reported
for zinc ﬁnger nucleases (37,38). As with chimeras,
this approach should also reduce oﬀ-target cutting
and increase the repertoire of novel sequence-speciﬁc
meganucleases. Moreover, the interface mutations can
immediately be applied to the many variants already
selected from I-CreI combinatorial libraries (7,9). This
removes one of the last hurdles on the way of using
meganucleases for gene therapy and other applications.
MATERIALS AND METHODS
Generation ofthe KTG and QANmeganucleases
I-CreI is a dimeric HE that cleaves a 24-bp pseudo-
palindromic target. Analysis of I-CreI structure bound to
its natural target shows that in each monomer, eight
residues establish direct interactions with seven bases (16).
Residues Q44, R68, R70 contact three consecutive base
pairs at position 3–5 (and 3t o5). An exhaustive
protein library versus target library approach was under-
taken to engineer locally this part of the DNA-binding
interface. First, the I-CreI scaﬀold was mutated from D75
to N to decrease likely energetic strains caused by the
replacement of the basic residues R68 and R70 in the
library that satisfy the hydrogen-acceptor potential of
the buried D75, in the wt I-CreI structure. The D75N
mutation did not aﬀect the protein folding, but decreased
the toxicity of I-CreI in over-expression experiments
(data not shown). Then, positions 44, 68 and 70 were
randomized and 64 palindromic targets resulting from
substitutions in positions 3, 4 and 5 of a palindromic
target cleaved by I-CreI were generated. Screening of the
64 palindromic targets with the protein library allowed the
identiﬁcation of new speciﬁcities for I-CreI (7). Among
these new variants mutations Q44K, R68T and R70G
recognized based CCT at positions 3, 4 and 5 (KTG
variant). Mutations Q44Q, R68A and R70N recognized
bases GTT at positions 3, 4 and 5 (QAN variant).
FoldX design
The diﬀerent heterodimers were designed using FoldX
(version 2.7), an automatic protein design algorithm
(32–34). As template, we used the crystal structure of
meganuclease I-CreI in complex with DNA (PDB code:
1g9y.pdb). We ﬁrst optimized the structure using the
<RepairPDB> command of FoldX, in order to release
any van der Waals clashes. We then mutated each position
of interest to alanine and, using the <BuildModel>
command, all models (heterodimers and homodimers
alike) were generated separately three times with diﬀerent
seeds to allow for ﬂexibility in surface side chains and to
cover more sampling space. Finally, each model of the
complex was analysed through the <AnalyseComplex>
command to compute the diﬀerent interaction energies,
and the values were averaged over the three models.
Cloning meganuclease mutants
The two homodimerizing meganucleases KTG and QAN,
based on the I-CreI meganuclease scaﬀold, were each
mutated at up to six amino acid positions to form two
compatible heterodimerizing interfaces, denoted KTG-A2
and QAN-B3. Mutations were introduced using round-
the-world PCR with a Quickchange kit (Stratagene, Cat.
200518).
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L97F) were introduced using three complementary primer
sets: (i) A1_RR_F, CAA TAC CAA ATA TAA CAG
GCG GTT CCT GCT GTA CCT GGC CG, A1_RR_R,
CGG CCA GGT ACA GCA GGA ACC GCC TGT TAT
ATT TGG TAT TG; (ii) A1_RF_F, TCA ACT GCA
GCC GTT TCT GAG ATT CAA ACA GAA ACA GGC
AAA CC, A1_RF_R, GGT TTG CCT GTT TCT GTT
TGA ATC TCA GAA ACG GCT GCA GTT GA;
(iii) A2_WLR_F, CCA GCG CCG TTG GTG GCT
GGA CAA ACT AGT GGA TAG AAT TGG CGT
TGG TTA CG, A2_WLR_R, CGT AAC CAA CGC
CAA TTC TAT CCA CTA GTT TGT CCA GCC ACC
AAC GGC GCT GG.
QAN-B3 mutations (K7E, F54G, L58M, K96E) were
introduced using three complementary primer sets:
(i) B3_EE_F, CAA TAC CAA ATA TAA CGA AGA
GTT CCT GCT GTA CCT GGC CG, B3_EE_R, CGG
CCA GGT ACA GCA GGA ACT CTT CGT TAT ATT
TGG TAT TG; (ii) B3_GME_F, CCA GCG CCG TTG
GGG TCT GGA CAA AAT GGT GGA TGA AAT
TGG CGT TGG TTA CG, B3_GME_R, CGT AAC
CAA CGC CAA TTT CAT CCA CCA TTT TGT CCA
GAC CCC AAC GGC GCT GG; (iii) B3_EL_F, TCA
ACT GCA GCC GTT TCT GGA ACT GAA ACA GAA
ACA GGC AAA CC, B3_EL_R, GGT TTG CCT GTT
TCT GTT TCA GTT CCA GAA ACG GCT GCA
GTT GA.
The ﬁrst primer set was used for PCR and transforma-
tion, according to the manufacturer’s instructions
(Stratagene, Quikchange). Approximately 300 transfor-
mant bacterial colonies were pooled in 2ml medium, and
plasmid DNA was recovered by miniprep. This DNA was
used as template for a second and then a third round of
PCR with mutagenic primers. Five third-round mutants
were veriﬁed by DNA sequencing.
Note that the dimer interface mutations are outside the
DNA recognition region and thus the primers above are
universal for any I-CreI mutant with altered speciﬁcity.
Similar methods were used to make the alternative designs
for the heterodimer pairs (QAN-A1, KTG-B3, QAN-B4),
introducing the appropriate mutations in the oligos for
mutagenic PCR (Figure 1).
Production and purification ofmeganucleases
Fresh BL21(DE3) (Stratagene) transformants carrying the
pET (Novagen) I-CreI mutants, were grown overnight in
5ml of Luria Broth (LB plus 30mg/ml kanamycin) at 378C
on a shaker. This pre-culture was expanded to a larger
culture (1:200). At an OD600nm of 0.6–0.8, ﬂasks were put
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Figure 1. Structure of the complex of meganuclease I-Cre-I (PDB:1G9Y) with its target DNA template. (A–C) Details of three modiﬁable interaction
patches between the two monomers on the homodimer. (D) Designed heterodimeric interfaces, showing amino acid changes at each relevant position
in the protein.
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by adding IPTG (1mM ﬁnal) for 18h at 168C, and cells
were harvested by centrifugation (15min, 16000g). Pellets
were re-suspended in 30-ml ice-cold lysis buﬀer (50mM
Tris–HCl, 200mM NaCl, 5mM MgCl2, 10% Glycerol,
10mM imidazole pH 8) containing 1ml/ml DNAse I and
the procedure was carried out at 48C thereafter. The
suspension was immediately frozen in liquid nitrogen and
thawed for 16h at 48C on a rotating platform (60r.p.m.).
The suspension was homogenized with an Ultra Turrax
T25 (Jankel & Kunkel, IKA-Labortechnik); three cycles
of 1min on ice) and then broken with an EmulsiFlex-C5
homogenizer (Avestin), each for ﬁve rounds of
500–1000psi (pounds per square inch). The lysate was
centrifuged at 150000g for 60min. This supernatant
was cleared through a 0.45mm ﬁlter (Millipore). A 5-ml
Hi-Trap column (Amersham-Pharmacia) was loaded with
two bead volumes (vol) of 250mM NiS04, and rinsed with
3vol of binding buﬀer (50mM Tris–HCl, 300mM NaCl,
1mM DTT, 20% glycerol, 10mM imidazole pH 8). The
supernatant was then applied to the column and washed
with washing buﬀer (binding buﬀer with 50mM imida-
zole) until the A280nm returned to its basal level. Protein
was eluted with elution buﬀer (0.3M imidazole). The
protein peak was collected and immediately applied to a
dialysis membrane (MWCO=3.5kDa, Spectra), placed
in 2l of dialysis buﬀer (50mM Tris–HCl, 200mM NaCl,
1mM DTT, 1mM EDTA, 50% glycerol pH 8) at 48C,
for at least 12h. The various stages of puriﬁcation
were analysed by SDS–PAGE (Supplementary Data
Figure S1). The puriﬁed protein was aliquoted and snap-
frozen in liquid nitrogen and stored at –808C. We noticed
that the diﬀerent enzymes had slightly diﬀerent apparent
activities, and that enzymes containing the QAN moiety
were less stable, losing activity entirely after several
months of storage at 808C. Thus, we used always an
aliquot only once and within 1 month of being prepared.
Analytical centrifugation
The oligomeric state of meganucleases and mutants was
investigated by monitoring sedimentation properties in
centrifugation experiments; 1.04mg of pure protein
was used per sample (0.52mg/ml of each monomer or
1.04mg/ml of individual WT homodimers) in storage
buﬀer (50mM Tris–HCl, 225mM NaCl, 1mm EDTA,
1mM DTT, 8% glycerol pH 8.0).
The sedimentation velocity proﬁles were collected by
monitoring the absorbance signal at 280nm as the samples
were centrifuged in a Beckman Optima XL-A centrifuge
ﬁtted with a four-hole AN-60 rotor and double-sector
aluminium centrepieces (186000g,4 8C). Molecular weight
distributions were determined by the C(s) method
implemented in the Sedﬁt (39) and UltraScan 7.1 software
packages (http://www.ultrascan.uthscsa.edu). Buﬀer den-
sity and viscosity corrections were made according to data
published by Laue et al. (40) as implemented in UltraScan
7.1. The partial speciﬁc volume of meganucleases and
mutants was estimated from the protein sequence accord-
ing to the method by Cohn and Edsall (41).
Co-expression of thedesigned monomers
In order to remove the His tag from the QAN-B3
monomer, it was excised from the parent plasmid
pCLS1214 (pET-series) with NcoI/NotI (New England
Biolabs). This fragment was then cloned into similarly cut
pCDFDuet1 plasmid (Novagen). TOP10 ultracompetent
cells (Invitrogen) were transformed with this mixture
and selected in 50mg/ml Streptomycin–Spectinomycin
sulphate. Clones were veriﬁed by DNA sequencing.
BL21(DE3) ultracompetent cells were co-transformed
with 10ng of each plasmid (pCLS1211-KTG-A2 and
pCDFDuet1-QAN-B3). The double transformants were
selected by growing the transformed colonies in presence
of Kanamycin and Streptomycin–Spectinomycin sulphate.
The puriﬁcation was performed essentially as above.
DNA digestion assays
Cleavage of the target sequences was determined as pre-
viously described (25) with modiﬁcations: co-expressed,
puriﬁed enzymes were diluted to 1mg/ml in fresh dialysis
buﬀer (in the case of the designed monomers which were
puriﬁed separately, 1.5mg of each monomer was added,
i.e. 0.5mg/ml each). Enzymes were stored at 808C.
Reaction mixtures contained appropriate amounts of
enzyme and DNA target, as indicated. DNA targets
were made from puriﬁed 3.2-kb plasmid containing the
appropriate target sequences (pre-linearized with XmnI)
and 225mM NaCl in a 20ml ﬁnal reaction volume. The
digestion mixtures were incubated for 60min at 378Ci na
water bath and then mixed with 2.5ml volume of Stop
solution (10), modiﬁed from Wang et al. (14) (50%
Glycerol, 0.1M EDTA, 0.5% SDS, 1mg/ml Proteinase K,
0.25% bromophenol blue). Samples were incubated for
30min more at 378C, and then half of each sample was
visualized on a 1% agarose gel.
For competition assays, DNA target sites of character-
istic lengths were constructed by PCR from the appro-
priate plasmid template. These templates were incubated
as above, for the times and reagent concentrations
indicated in each individual experiment. The gels were
scanned and quantitated for image intensity of cleavage
bands using imageJ. Activity curves were determined by
non-linear regression, using Kaleidagraph 4.0 for the
equation: Cleavage (%)=m1m0/(m0+m2), where m0 is
protein concentration (in mM), and the parameters m1 and
m2 represent maximum cleavage (%) and enzyme con-
centration for 50% cleavage (mM), respectively.
RESULTS
Protein design
To design the heterodimeric interface of I-CreI, we used
the X-ray structure of the homodimer determined at
2.05A ˚ resolution (PDB: 1g9y), bound to its cognate DNA
target sequence. The aim was to facilitate heterodimeriza-
tion and at the same time to prevent the formation of
homodimers, or at least make them thermodynamically
unstable.
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homodimer is composed of two a-helices (Lys7 to Gly19
in both monomers), arranged in a coiled-coil. The two
helices are very close to each other, packing in the centre
mainly through the backbone, making them unsuitable for
re-design. The amino acids below these helices (Asp20 and
onward) are contacting the DNA and are thus responsible
for both the activity (active site) and speciﬁcity (DNA
recognition) of the endonucleases. These functions alone
prevent any of these residues to be modiﬁed in the design
process. This left us with few possibilities to enforce
the heterodimerization. After careful examination of the
structure, we identiﬁed three patches of interactions
involved in the interface that could be disturbed and
changed in the dimers, without impairing their binding
capacity or their enzymatic activity (Figure 1).
The most obvious one of these is the region above the
two helices (Figure 1A), where Lys7 and Glu8 in one
monomer establish favourable electrostatic interactions
with the corresponding residues in the other monomer.
In order to keep this interaction in the heterodimer, and at
the same time impair monomer formation, we decided
to replace them with two arginines in one monomer
(named monomer A hereafter) and two glutamates in the
other (called monomer B). Thus, AA and BB homodimers
would undergo an electrostatic repulsion whereas
AB heterodimer formation would be electrostatically
favourable.
The second patch was chosen with the same idea of
creating small electrostatic imbalances for homodimers,
relative to heterodimers, but is positioned on each side of
the coiled-coil; a double cluster of charged residues is
made by the Lys96 and the Glu61 of each monomer
(Figure 1B). To re-enforce the electrostatic eﬀects of the
ﬁrst mutation site, we decided to mutate the second site
with two arginines in monomer A, and two glutamates
in monomer B, thus making a charged triangle in each
monomer (positive in A, negative in B).
The third region of interest is the region around the
middle of the two helices involved in the interaction surface
and is mainly composed of hydrophobic interactions and
hydrogen bonds, making a kind of minicore. As the
H-bond network is quite intricate and extends all the way
to the active site, we decided to perturb only the
hydrophobic patch made by residues Tyr12, Phe16,
Val45, Trp53, Phe54, Leu55 and Leu58 of one monomer,
with residue Leu97 of the other monomer (the latter acting
like a cap closing the hydrophobic pocket; Figure 1C). We
re-designed these two pockets in order to introduce strong
Van der Waals’ Clashes in the homodimers without
disturbing the hydrophobic interactions in the heterodi-
mers (i.e. without creating cavities and steric clashes). For
this we decided to introduce bulky residues in monomer A
(respectively Phe or Trp for position 54 and Phe for
position 97 and small residues in monomer B (Gly and
Leu, respectively). A glycine could be introduced at
position 97 to give more space to position 54 when it is
mutated in tryptophan. As a result, AA homodimers
develop huge steric hindrance, preventing their formation,
and BB homodimers contain big cavities, making them
unstable. By contrast, the minicore of AB heterodimers
should be ﬁlled eﬃciently by these compatible amino acids.
Finally, we mutated Leu58 to methionine in monomer B,
to prevent any cavity formation in the heterodimer, due to
the introduction of the small side chains.
We thus deﬁned two types of monomer A, A1 and A2,
depending of the nature of the amino acid at position 54,
respectively Phe or Trp, and two types of corresponding
monomer B, B3 and B4, the later diﬀering by a mutation
in Glycine at position 97 to accommodate with the Trp
mutation of monomer A2 (Figure 1D). The diﬀerent
mutations were tested with FoldX to model all homo-
dimers (A1:A1, A2:A2, B3:B3 and B4:B4) and hetero-
dimers (A1:B3, A2:B3 and A2:B4) and to get the diﬀerent
interaction energies (Table 1). Of all the heterodimers, two
constructions, A1:B3 and A2:B3, presented a computed
interaction energy close to the wild-type homodimer
(Table 1). The last construction, A2:B4, presented
a signiﬁcant decrease in interaction energy compared to
the wild-type homodimer but was nonetheless signiﬁcantly
higher than the mutant homodimers. Conversely, A1:A1,
A2:A2, B3:B3 and B4:B4 homodimers were all much
destabilized and thus these species were expected to
remain monomeric.
Optimizing conditions forspecific DNA cleavage
To verify that we were able to design a speciﬁc het-
erodimer correctly, we employed two meganuclease
variants that recognize diﬀerent DNA sequences (7).
These variants both harbour an Asp75 to Asn mutation
that decreases energetic strains caused by the replacement
of the basic residues Arg68 and Arg70; these arginines
normally satisfy the hydrogen-acceptor potential of the
buried Asp75 in the I-CreI structure. We used the
meganuclease denoted as ‘KTG’, which diﬀers from
the WT at positions 44, 68 and 70 and recognizes the
bases CCT at positions 4, 5 and 6 of the DNA target.
The other meganuclease is called ‘QAN’, diﬀers from the
WT at the same positions, and recognizes the bases GTT
at positions 4, 5 and 6 of the DNA target. These two
enzymes have been obtained by screening of a library of
I-CreI derivatives mutated at positions 44, 68 and 70 (7).
Throughout this paper, we denote the target DNA
sequences by a 6-base code, with the ﬁrst three bases
corresponding to positions 4, 5 and 6 of the target
sequence and the second three to the same positions in the
complementary DNA sequence; the two triplets are
Table 1. FoldX calculated interaction energies (kcal/mol) between
wild-type and designed homodimers and heterodimers
Dimers Diﬀerence in interaction energies between
mutants and wild-type (kcal/mol)
A2_B3 0.13
A1_B3 0.22
A2_B4 3.20
B3_B3 7.39
A1_A1 8.30
A2_A2 8.53
B4_B4 11.96
The best binding energy (A2_B3) corresponds with the best in vitro
result.
Nucleic Acids Research, 2008, Vol. 36, No. 7 2167separated by a slash (/). Thus, the target of the KTG
enzyme is CCT/AGG that for the QAN target is
GTT/AAC, and the mixed DNA target for the hetero-
dimer KTG-QAN is denominated as GTT/AGG.
For the WT meganuclease I-CreI, it has been reported
(14) that the ideal conditions for digestion of its target
DNA are: 20mM Tris–HCl (pH 8.0–9.0) with 10mM
MgCl2, and the enzyme is reportedly inhibited above
25mM NaCl ionic strength. However, when using
the KTG and QAN enzymes, we actually found that
optimal (although not perfect) speciﬁcity and activity
were achieved around 225mM NaCl concentration
(Supplementary Data, Figure S2). At lower ionic
strengths, there was suboptimal speciﬁcity. This suggests
that strong binding of only one of the monomers to the
DNA is enough to allow digestion. Increasing ionic
strength to 225mM both improves the activity of the
enzymes towards their targets and reduces the digestion of
the mixed template. Nonetheless, further increasing NaCl
concentration to 250 and 300mM actually slightly
reduced cleavage activity (data not shown). This beha-
viour could be explained by the ionic strength decreasing
the aﬃnity for DNA (thus preventing binding if only one
monomer establishes speciﬁc interactions in the dimer). As
a result of these tests, we selected the following optimal
buﬀer for digestion of our meganuclease designs: 25mM
HEPES (pH 8), 5% Glycerol, 10mM MgCl2 and 225mM
NaCl (see Materials and methods section).
Expression and characterization ofthe designedmutants
The designed mutants A1, A2, B3 and B4 were obtained
by site-directed mutagenesis (Stratagene, QuikChange
Kit) of the original KTG and QAN enzyme expression
vectors, and the corresponding proteins expressed and
puriﬁed (Supplementary Data S1). We did not construct
every combination of possible variants but rather
selected only QAN-A1, KTG-B3, KTG-A2, QAN-B3
and QAN-B4. These were designed to give coverage of all
the designed heterodimer interactions A1:B3, A2:B3 and
A2:B4, resulting in the heterodimers QAN-A1:KTG-B3,
KTG-A2:QAN-B3 and KTG-A2:QAN-B4.
Whereas the wild-type KTG and QAN enzymes yield
the majority of protein in the soluble fraction (data not
shown), we found the opposite in the case of the designed
enzymes: the majority of the expressed proteins remained
in inclusion bodies in the pellet, only a small fraction
could be puriﬁed, and even this was contaminated by
other proteins (Supplementary Data S1). This was a ﬁrst
indication that our designed variants cannot homodimer-
ize and thus become unstable and aggregate when
expressed individually.
We tested the activity of the puriﬁed A1, A2, B3 and B4
enzymes on the three DNA targets (Figure 2) at low and
high ionic strength (50mM or 225mM NaCl). At low salt,
we detected general cleavage of both cognate and non-
cognate targets with these mutant monomer designs. At
high ionic strength, we could not detect the expected two
DNA bands, although the amount of DNA decreased
unspeciﬁcally in some cases, upon incubation with the
enzymes (probably because of the low yield of the enzymes
which resulted in a proportionally larger amount of
contaminants). These results were marred by the low
yield and quality of the protein obtained when the non-
homodimerizing monomer designs were expressed indi-
vidually; even with a large 6l volume of bacteria yielding
inadequate protein (between 0.5 and 1.5mg/ml for
designed monomers compared with 30mg/ml for wild-
type dimerizing monomers).
To check the oligomeric status of the puriﬁed designed
enzymes we measured their size proﬁles by analytical
ultra-centrifugation (see Figure 3 and Materials and
methods section). In the case of individually expressed
A1, A2, B3 and B4 proteins, we observed the appearance
of the expected monomeric enzyme. However, we also saw
higher molecular weight aggregates, including trimers and
tetramers (Figure 3B; only KTG-A2 and QAN-B3 are
shown, although similar results were obtained with the
other designs). Therefore, the designed enzymes were
indeed unable to homodimerize, and this may have
aﬀected their stability and aggregation properties during
puriﬁcation.
To investigate the potential for heterodimerization, we
mixed equimolar quantities of the individually puriﬁed
designed enzymes (QAN-A1, QAN-B3, QAN-B4,
KTG-A2 and KTG-B3) in all possible combinations.
In the case of the KTG-A2/QAN-B3 (the best heterodimer
design), we saw the appearance of a major species
corresponding to the molecular weight of the dimer, but
this was not the only species formed. For the pair
QAN-A1/KTG-B3 and KTG-A2/QAN-B4, we saw the
appearance of new peaks of molecular mass between the
monomer and dimer, and a decrease of high molecular
weight aggregates (data not shown). For those combina-
tions that should not produce a heterodimer, we did not
see signiﬁcant changes in the behaviour of the proteins.
Overall, these results indicated that the design might have
QAN: GTT/AAC KTG: CCT/AGG Q-K: GTT/AGG DNA: 
N
a
C
l
:
 
5
0
 
m
M
  A 
B 
3.2
kb
M
3.2
2.1
1.1
kb
Q
A
N
-
A
1
Protein: 
Q
A
N
-
B
3
Q
A
N
-
B
4
K
T
G
-
A
2
K
T
G
-
B
3
* * *
Q
A
N
-
A
1
Q
A
N
-
B
3
Q
A
N
-
B
4
K
T
G
-
A
2
K
T
G
-
B
3
Q
A
N
-
A
1
Q
A
N
-
B
3
Q
A
N
-
B
4
K
T
G
-
A
2
K
T
G
-
B
3
N
a
C
l
:
 
2
2
5
 
m
M
 
Figure 2. Non-speciﬁc DNA cleavage and non-cleavage by singly
expressed designed meganuclease monomer variants under diﬀerent salt
conditions. Approximately 3.75mM of each puriﬁed protein was
incubated with 3nM of puriﬁed plasmid (pre-linearized with XmnI),
containing either the QAN homodimer site (GTT/AAC), the KTG
homodimer DNA site (CCT/AGG) or a hybrid site QAN/KTG site
(Q-K: GTT/AGG). The concentration of NaCl was either (A)5 0 m M
or (B) 225mM. Arrows indicate the uncut target DNA (3.2kb) or the
two bands resulting from digestion (1.1 and 2.1kb). An asterisk ()
marks control lanes with DNA alone. One-kilobase ladders
(Fermentas) are marked by M.
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dimerizing monomers, followed by in vitro reconstitution,
was not an eﬀective strategy (probably because a large
fraction of the protein was partly aggregated; see above).
Thus, we decided to attempt co-expression within the
bacterial cell.
Co-expression and activity ofthe designed mutants
The above results suggested that the heterodimer designs
might have been functioning, but that the expression of the
monomeric enzymes resulted in strong aggregation and
thus in partly inactive enzymes. To avoid this problem, we
subcloned the monomer gene expression cassettes into
complementary plasmids and co-transformed into bacter-
ial cells, such that one monomer would be expressed
(with a His-tag) from the original pET-series plasmid and
that the partner monomer would be expressed (without
a His-tag) from a compatible pCDFDuet-I vector
(Novagen). Dual antibiotic selection ensured that each
cell contained both plasmids.
Expression analysis of the co-expressed KTG-A2/
QAN-B3 proteins showed that inclusion bodies were
avoided, suggesting that the previous aggregation problem
had been solved. SDS–PAGE analysis of the puriﬁed
enzyme subsequently revealed two bands with
approximately the same amount of protein, suggesting
that we were purifying the heterodimer and not homo-
dimer (Supplementary Figure S1B). Furthermore, an
analytical ultra-centrifugation of the puriﬁed proteins
gave an exceptionally clean single proﬁle at the expected
molecular weight for a dimer (Figure 3C). We carried out
digestion of the various DNA targets with the puriﬁed
co-expressed heterodimer designs and found a clear
preference for cleavage of the heterodimer DNA target
(GTT/AGG), relative to the homodimeric targets (CCT/
AGG and GTT/AAC) by KTG-A2/QAN-B3 (Figure 4A).
Thus, we can conclude that the protein design exercise was
successful and that we are able to create functional
heterodimeric I-CreI enzyme variants, as long as the
monomer moieties are co-expressed.
Co-expression experiments were also carried out for the
other protein designs. QAN-A1/KTG-B3 proteins showed
mixed results; there were indeed two bands after puriﬁca-
tion, indicating heterodimer formation. However, one
band was stronger than the other and while there
was speciﬁc cleavage of the heterodimer, this was at a
reduced level as compared to the KTG-A2/QAN-B3
combination (data not shown). Analytical centrifugation
showed formation of a dimer with a small proportion
of aggregate. The third co-expression combination,
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puriﬁed and a monomer detected by analytical centrifuga-
tion (Figure 3D). Therefore, this design failed to make a
heterodimer, even when co-expressed. Interestingly
enough, the proportion of dimer and activity between
KTG-A2/QAN-B3, QAN-A1/KTG-B3 and KTG-A2/
QAN-B4 correlate perfectly well with the energies
predicted by FoldX (Table 1). The best design, in terms
of predicted energy in silico, forms the best heterodimer
in vitro.
Although the KTG-A2/QAN-B3 heterodimer preferen-
tially cleaved the hetero-DNA target, it could have been
possible that it was less active. To rule out this, we
compared the activities of the QAN, KTG and KTG-A2/
QAN-B3 in a time-course (Figure 4B). This experiment
shows that KTG and the heterodimer have similar
activities, whereas QAN requires four times longer
incubation for 50% cleavage of its substrate, using the
same apparent protein concentration.
Specificity in competitive cuttingassays
To measure the relative discrimination of the enzymes for
homodimer and heterodimer DNA sites, we carried out
competition experiments where the enzymes had access to
equimolar amounts of both substrates simultaneously
(Figure 5). We selected the KTG-A2/QAN-B3 hetero-
dimer and KTG-wt for these experiments, because they
exhibited similar activities against their respective targets
(Figure 4B). In a time course experiment, KTG cleaved its
target preferentially, although there was a slight digestion
of the KTG-A2/QAN-B3 target cognate site (Figure 5A).
By contrast, KTG-A2-QAN-B3 heterodimer preferentially
cleaved the Q-K heterodimer DNA with little cleavage of
the KTG site.
To compare the relative cutting preferences more
directly, an enzyme titration was carried out against
equimolar mixtures of both DNA targets (Figure 5B).
This allowed the determination of the apparent concen-
trations for 50% cleavage for cognate and non-cognate
targets under competitive conditions: KTG-wt for cognate
target=0.1mM; KTG-wt for non-cognate target=
1.5mM; KTG-A2/QAN-B3 for cognate target=0.3mM;
KTG-A2/QAN-B3 for non-cognate target=3.2mM.
Therefore, for both enzymes there was found to be an
approximate 10- to 15-fold diﬀerence in enzyme concen-
tration separating 50% cleavage of the cognate and the
non-cognate targets.
In summary, these results show that although the
speciﬁcities of both the parent constructs and the mutant
derivatives are not absolute, we were able to design
obligate heterodimer meganucleases which have similar
activity to the best wt parent, and a clear cleavage
preference for their heterodimer targets, whereas the
original homodimers have the opposite preference for
their homodimer targets.
DISCUSSION
The making of artiﬁcial endonucleases with tailored
speciﬁcities has paved the way for novel applications in
several ﬁelds, including gene therapy. For example,
meganuclease-induced recombination can be used for the
correction of mutations linked with monogenic inherited
diseases such as SCID, SCA or CFTR (5). This strategy
has the advantage to bypass the odds associated with
current strategies of random insertion of a complementing
transgene. Several reports have also shown that engi-
neered zinc-ﬁnger nucleases can trigger eﬃcient site-
directed recombination in mammalian cultured cells,
plants and insects (42–46). However, zinc ﬁnger-derived
nucleases (ZFNs) have proven to be toxic in Drosophila
(42,46,47) and mammalian NIHT3 cells (48–50),
a genotoxic eﬀect that is probably due to frequent oﬀ-site
cleavage (45). Although HEs have shown to be less toxic
(probably because of better speciﬁcity) by diﬀerent groups
(48–50), they can still be harmful at very high doses (51).
Oﬀ-site cleavage is severely enhanced by the formation
of protein engineering by-products. Most engineered
endonucleases (ZFNs and HEs) so far are heterodimers,
and include two separately engineered monomers, each
binding one half of the target. Heterodimer formation is
obtained by co-expression of the two monomers in the
same cells (9,45). This is actually associated with
the formation of two unwanted homodimers (7,47),
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(pre-linearized with XmnI), containing either the QAN homodimer
site (GTT/AAC), the KTG homodimer DNA site (CCT/AGG) or a
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2170 Nucleic Acids Research, 2008, Vol. 36, No. 7recognizing diﬀerent targets, and individual homodimers
can sometimes result in an extremely high level of toxicity
(47). This problem is well known in the ﬁeld and there
have been several previous approaches to overcome it.
In the case of ZFNs, two recent reports have tackled
this issue directly, with approaches that are related to the
work presented here with meganucleases. ZFNs function
by having two zinc ﬁnger DNA-binding domains, each
fused to a FokI nuclease domain, which cuts DNA as a
dimer. FokI dimerization is relatively weak and is thought
to occur primarily once both DNA-binding domains have
bound their target DNAs (52). Miller and co-workers (37)
therefore employed a step-wise sequential rational design
approach to make obligate FokI heterodimers that would
function in the context of DNA-binding speciﬁcity
provided by custom-designed zinc ﬁngers. This was very
successful in that not only did the zinc ﬁngers form
obligate heterodimers that cut the heterodimer DNA
sites in vitro, with little or no discernible cutting of
the homodimer sites, but this actually translated to a
reduction in genomic DNA damage in vivo, as measured
by an antibody-mediated assay for sites associated with
DNA damage. In a complementary approach, Szczepek
et al. (38) used computer-aided design in a similar zinc
ﬁnger-FokI system to actually reduce general dimerization
of FokI, thus ensuring that cleavage would tend to be at
DNA sites where complementary zinc ﬁngers bound
speciﬁcally, in the correct orientation. Similarly, assays
for DNA damage in vivo showed that the mutant FokI
design had reduced general toxicity, while maintaining
suﬃcient activity to drive homologous recombination.
In the case of meganucleases, previous studies have also
shown that it is possible to re-design protein–protein
interfaces so to gain the advantages of generating new,
selective binding speciﬁcities. For example, Chevalier
and colleagues (26), carried out a challenging protein
computational-design approach to re-engineer new, func-
tional fusion chimeras of I-DmoI and I-CreI endonuclease
domains. This required extensive computational explora-
tion, over 14 amino acid residue positions, and resulted in
a functional chimera with eight designed point mutations.
The authors concluded that it would be possible to make
many new sequence-speciﬁc endonucleases by taking
natural monomer domains and building such new
chimeras. However, it is worth noting that in the
I-DmoI–I-CreI fusion the chimera was created by
connecting the two monomer domains with a short
peptide linker of only 3 amino acids. This possibility
was not available for making I-CreI 2-unit chimeras
because the N- and C-termini of each monomer are
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Nucleic Acids Research, 2008, Vol. 36, No. 7 217168A ˚ apart, which would require a very long linker of
around 25–30 amino acids. Using a long linker could in
theory result in a functional fusion of the two monomers
in a single chain molecule. However, this kind of design is
relatively perilous, and can result in concatemers, badly
folded proteins and unstable, easily degraded linker
regions. In another approach, a linker of 10bp was used
to connect two I-CreI monomers (25), but the use of this
shorter sequence was only made possible by truncating the
ﬁrst I-CreI monomer by one-third. This deletion resulted
in a shorter distance between the amino acids connected
by the linker, but had also a signiﬁcant impact on protein
solubility (data not shown). This therefore prompted us to
attempt the obligate heterodimer approach for I-CreI.
It should also be noted that there exists in the literature
a history of re-engineering HE interfaces to control
homodimerization itself. For example, the LAGLIDAD
interface has been extensively studied by Silva and Belfort
(35) who grafted residues from I-CreI helices onto I-DmoI
domains. I-Dmo is a natural monomer, whereas I-CreI is a
dimer, and the helix graft resulted in dimeric I-DmoI
which acted as a nickase rather than a double-strand
breaking nuclease. Double-strand cleavage activity could
then be improved by reversion of speciﬁc helix residues.
This work illustrates the diﬃculty sometimes encountered
in re-engineering enzymes: a functional interface can
yet be incompatible with full enzyme functionality.
Nonetheless, this study gave insights into the relative
contributions of parts of the LAGLIDAD helix, delineat-
ing the sensitivity to mutation of regions such as the
C-terminal 10 residues, which contribute to the endonu-
clease active site. Furthermore, the authors later extended
this work by re-engineering I-DmoI LAGLIDAD inter-
faces (using I-CreI-derived mutations) to give functional
homodimer interfaces and full enzyme activity (36). They
were also able to use a short 2 amino acid peptide linker to
make fused dimer constructs with 3-fold higher activity
over unlinked dimer. However, there was evidence that the
improvement in activity was due to changes in the active
site conﬁguration rather than improved homodimeriza-
tion. These studies show how interface mutations in HEs
are intimately linked with cleavage activity.
In summary, the speciﬁcity problem of heterodimer
meganucleases might have been approached by (i) the
suppression of any dimer formation in the absence of
DNA interactions (38), (ii) the design of favourable
heterodimerization and unfavourable homodimerization
(37) or (iii) interface re-design and direct peptide linkage
to make chimeras between two monomers (25,26). The
engineering of obligatory heterodimers was chosen in this
study as the simplest alternative that provides functional,
well-folded proteins in the context of the pure I-CreI
scaﬀold. Using only four complementary amino acid
mutations on each monomer (KTG-A2 and QAN-B3
designs), we were able to generate preferential hetero-
dimerization and target site recognition when the mono-
mers were co-expressed.
Hundreds of homodimeric I-CreI derivatives with
locally altered speciﬁcity have been described in previous
reports (7,9), and it has been shown that such proteins
could be co-expressed to form heterodimers. However, the
possibility to combine these proteins into obligatory
heterodimers, as shown here, will dramatically improve
the ability to engineer more speciﬁc reagents for genome
engineering. For therapeutic applications, which require a
minimal genotoxicity, this gain in speciﬁcity might simply
make all the diﬀerence.
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